Authors : Afreen Usmani, Rania I.M. Almoselhy
DOI : 10.18231/j.ijnmhs.2023.027
Volume : 6
Issue : 4
Year : 2024
Page No : 161-170
The current study explores the transformative journey of L. (Olive) from its traditional role in random traditional medicine to its current positioning in pharmacopeia as a pharmaceutical preparation with defined dosage and indications. The comprehensive examination covers botanical and chemical profiles, traditional uses, pharmacological activities, extraction techniques, quality control, regulatory status, clinical studies, and future directions. Various analytical methods, including spectroscopic and chromatographic approaches, are discussed for quality evaluation and detection of adulteration. Additionally, the regulatory landscape, particularly within the European Union, is outlined, emphasizing the importance of accurate labeling and geographical origin disclosure. The regulatory status of L. varies across regions, ranging from restrictions due to safety concerns to inclusion in pharmacopeias as traditional herbal medicine or pharmaceutical preparations. A pivotal development highlighted is the incorporation of Olive into Egyptian pharmacopeia, signifying a significant shift towards evidence-based therapy and reinforcing its acceptance in mainstream healthcare.